Cost Benefit Analysis of Research and Development of Top 10 Biotechnology Companies
Cost Benefit Analysis of Research and Development of Top 10 Biotechnology Companies
RELEASE DATE
15-Jun-2005
15-Jun-2005
REGION
North America
North America
Research Code: F246-01-00-00-00
SKU: HC01435-NA-MR_05899
$2,450.00
Special Price $1,837.50 save 25 %
In stock
SKU
HC01435-NA-MR_05899
Description
The research service profiles the top 10 biotechnology companies and incorporates a unique risk-return model to analyze the research and development pipeline of these companies. Cost-Benefit analysis for these companies and the industry has also been undertaken in this research service.
Table of Contents
Overview of the Biotechnology Industry
- Industry Structure
- Technology and Processes
- Research and Development Process
- Top 10 Companies
- Disclaimer
Frost & Sullivan Awards
- Best Cost-Benefit Value Award
- Best Risk-Return Value Award
Methodology
Amgen Inc.
- Risk Return Analysis
- Cost Benefit Analysis
Biogen Idec Inc.
- Company Profile
- Research and Development
- Risk Return Analysis
- Cost Benefit Analysis
Chiron Corporation
- Company Profile
- Research and Development
- Risk Return Analysis
- Cost Benefit Analysis
Genentech, Inc
- Company Profile
- Research and Development
- Risk Return Analysis
- Cost Benefit Analysis
Genzyme Corporation
- Company Profile
- Research and Development
- Risk Return Analysis
- Cost Benefit Analysis
Gilead Sciences, Inc
- Company Profile
- Research and Development
- Risk Return Analysis
- Cost Benefit Analysis
InterMune, Inc
- Company Profile
- Research and Development
- Risk Return Analysis
- Cost Benefit Analysis
MedImmune, Inc
- Company Profile
- Research and Development
- Risk Return Analysis
- Cost Benefit Analysis
Millennium Pharmaceuticals, Inc
- Company Profile
- Research and Development
- Risk Return Analysis
- Cost Benefit Analysis
Serono Inc.
- Company Profile
- Research and Development
- Risk Return Analysis
- Cost Benefit Analysis
Industry Analysis
Popular Topics
The research service profiles the top 10 biotechnology companies and incorporates a unique risk-return model to analyze the research and development pipeline of these companies. Cost-Benefit analysis for these companies and the industry has also been undertaken in this research service.
No Index | No |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | F246-01-00-00-00 |
Is Prebook | No |